These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17470315

  • 1. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA, Ait-Daoud N, Elkashef AM, Smith EV, Kahn R, Vocci F, Li SH, Bloch DA, Methamphetamine Study Group.
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [Abstract] [Full Text] [Related]

  • 2. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA.
    Drug Alcohol Depend; 2006 Oct 01; 84(3):256-63. PubMed ID: 16631323
    [Abstract] [Full Text] [Related]

  • 3. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Baker AL, Sinclair B, Reid D, Manning V, Te Pas N, Liang W, Thomas T, Bathish R, Kent M, Raftery D, Arunogiri S, Cordaro F, Hill H, Berk M.
    Trials; 2019 Jun 04; 20(1):325. PubMed ID: 31164169
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM.
    Addiction; 2010 Jan 04; 105(1):146-54. PubMed ID: 19839966
    [Abstract] [Full Text] [Related]

  • 5. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N, Dunlop A, Hall M, Ali R, McKetin R, Bruno R, Phung N, Carr A, White J, Clifford B, Liu Z, Shanahan M, Dolan K, Baker AL, Lintzeris N.
    BMJ Open; 2018 Jul 19; 8(7):e020723. PubMed ID: 30030312
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A.
    Addiction; 2009 Feb 19; 104(2):224-33. PubMed ID: 19149817
    [Abstract] [Full Text] [Related]

  • 7. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, Marshall AM, Daughters RS, Banerjee-Stevens D, Eckert ED, Hartman BK.
    Lancet; 2000 Mar 04; 355(9206):792-7. PubMed ID: 10711927
    [Abstract] [Full Text] [Related]

  • 8. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J.
    Addiction; 2013 Jul 04; 108(7):1279-86. PubMed ID: 23297867
    [Abstract] [Full Text] [Related]

  • 9. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
    Rezaei F, Emami M, Zahed S, Morabbi MJ, Farahzadi M, Akhondzadeh S.
    Daru; 2015 Jan 15; 23(1):2. PubMed ID: 25588930
    [Abstract] [Full Text] [Related]

  • 10. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
    Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID.
    Psychopharmacology (Berl); 2001 Feb 15; 154(1):23-7. PubMed ID: 11292002
    [Abstract] [Full Text] [Related]

  • 11. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D.
    Neuropsychopharmacology; 2008 Apr 15; 33(5):1162-70. PubMed ID: 17581531
    [Abstract] [Full Text] [Related]

  • 12. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ, Razaghi E, Moazen-Zadeh E, Safi-Aghdam H, Zarrindast MR, Vousoghi N, Akhondzadeh S.
    Int Clin Psychopharmacol; 2018 Mar 15; 33(2):111-119. PubMed ID: 29064909
    [Abstract] [Full Text] [Related]

  • 13. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ.
    Int J Neuropsychopharmacol; 2007 Feb 15; 10(1):85-98. PubMed ID: 16448579
    [Abstract] [Full Text] [Related]

  • 14. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL, Li SH, Markova D, Holmes TH, Chiang N, Kahn R, Campbell J, Dickerson DL, Galloway GP, Haning W, Roache JD, Stock C, Elkashef AM.
    Drug Alcohol Depend; 2015 May 01; 150():170-4. PubMed ID: 25818061
    [Abstract] [Full Text] [Related]

  • 15. A prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
    Dawes MA, Johnson BA, Ait-Daoud N, Ma JZ, Cornelius JR.
    Addict Behav; 2005 Jul 01; 30(6):1077-85. PubMed ID: 15925118
    [Abstract] [Full Text] [Related]

  • 16. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F, Ghaderi E, Mardani R, Hamidi S, Hassanzadeh K.
    Fundam Clin Pharmacol; 2016 Jun 01; 30(3):282-9. PubMed ID: 26751259
    [Abstract] [Full Text] [Related]

  • 17. Ondansetron in the treatment of cognitive decline in Alzheimer dementia.
    Dysken M, Kuskowski M, Love S, Ondansetron Study Group.
    Am J Geriatr Psychiatry; 2002 Jun 01; 10(2):212-5. PubMed ID: 11925283
    [Abstract] [Full Text] [Related]

  • 18. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG, Swanson AN, Kim S, Cederblom L, Moe A, Ling W, Shoptaw S.
    Drug Alcohol Depend; 2010 Jun 01; 109(1-3):20-9. PubMed ID: 20092966
    [Abstract] [Full Text] [Related]

  • 19. Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial.
    Akhondzadeh S, Mohammadi N, Noroozian M, Karamghadiri N, Ghoreishi A, Jamshidi AH, Forghani S.
    Schizophr Res; 2009 Feb 01; 107(2-3):206-12. PubMed ID: 18789844
    [Abstract] [Full Text] [Related]

  • 20. Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial.
    Farahzadi MH, Moazen-Zadeh E, Razaghi E, Zarrindast MR, Bidaki R, Akhondzadeh S.
    J Psychopharmacol; 2019 Mar 01; 33(3):305-315. PubMed ID: 30526230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.